Arrowhead Research | ARWR - EPS - Lucro por Ação

Preço das Ações
74.40
Mudança Diária
0.48 0.65%
Mensal
32.22%
Anual
457.72%
Q2 Previsão
67.98

Fiscal Calendário Atual Consenso Anterior Data
FY2026Q2 Mar/2026 -1.04 2.75 May/07
FY2026Q1 Dec/2025 0.22 0.04 -1.39 Feb/05
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12




Eps Alterar Data
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Novartis USD 1.54 0.5 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
TG Therapeutics USD 0.14 2.29 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xencor USD -0.09 0.01 2025-12